SCHEMBL6162861

SCHEMBL6162861

Cc1nn(-c2ccccn2)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 13/20 0.65
CCNA2 P20248 6/20 0.61
CDK2 P24941 6/20 0.61
CCNO P22674 1/20 0.61
CCNE1 P24864 1/20 0.61
CCNA1 P78396 1/20 0.61
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
THRB P10828 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
OPRK1 P41145 2/20 0.54
OPRD1 P41143 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164595 0.84 CCNA2 (0.47) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6167069 0.84 CCNA2 (0.47) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6162155 0.83 OPRM1 (0.57) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6167358 0.82 ALDH1A1 (0.57) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6164588 0.81 LMNA (0.70) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6164586 0.81 LMNA (0.70) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6166305 0.81 OPRM1 (0.76) OPRM1ALDH1A1SMN1; SMN2OPRK1OPRD1
SCHEMBL6164703 0.81 OPRM1 (0.45) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6167242 0.80 ALDH1A1 (0.62) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6164944 0.77 CCNA2 (0.62) CCNA2CDK2CCNOCCNE1CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP claimed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US claimed
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed